Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Rhode Island Medical Journal (2013)|December 5, 2018
Helping Ambulatory Practices Succeed: Reflections from Practice Transformation FacilitatorsPutney Pyles, Kimberly Pelland, Vicki Crowningshield, et al.
Rhode Island Medical Journal (2013)|June 10, 2015
The Nuts and Bolts of Long-term Care In Rhode Island: Demographics, Services and CostsKimberly Pelland, Teresa Mota, Rosa R Baier
Rhode Island Medical Journal (2013)|July 8, 2017
Results from a Community-Wide Pilot Program to Standardize COPD Education for Patients Across Healthcare Settings in Rhode IslandKimberly Pelland, Rouba Youssef, Kathleen Calandra, et al.
International Journal of Environmental Research and Public Health|April 27, 2024
User Manual for Coping Strategies Inventory Short Form (CSI-SF)-The Jackson Heart StudyClifton Addison, Brenda Jenkins, Monique White
Journal of General Internal Medicine|July 22, 2018
Use of Chronic Care Management Codes for Medicare Beneficiaries: a Missed Opportunity?Rebekah L Gardner, Rouba Youssef, Blake Morphis, et al.
Journal of the American Medical Directors Association|December 9, 2019
Reducing Hospital Readmissions Through a Skilled Nursing Facility Discharge Intervention: A Pragmatic TrialRebekah L Gardner, Kimberly Pelland, Rouba Youssef, et al.
Diseases (Basel, Switzerland)|December 22, 2023
Mortality Trends in Alzheimer's Disease in Mississippi, 2011-2021Elizabeth A K Jones, Brenda Jenkins, Clifton Addison
International Neurourology Journal|April 5, 2019
A Korean Postmarketing Study Assessing the Effectiveness of OnabotulinumtoxinA for the Treatment of Neurogenic Detrusor Overactivity or Idiopathic Overactive Bladder Using a Validated Patient-Reported Outcome MeasureKwang Jin Ko, Brenda Jenkins, Anand Patel, et al.
Journal of Pediatric Urology|June 21, 2024
Results of a study examining the use of onabotulinumtoxinA in pediatric patients with overactive bladderPiet Hoebeke, Adam Hittelman, Brenda Jenkins, et al.
Medicine|July 27, 2023
Treatment of neurogenic detrusor overactivity and overactive bladder with Botox (onabotulinumtoxinA): Development, insights, and impactVictor Nitti, Cornelia Haag-Molkenteller, Michael Kennelly, et al.
Pageof 3